Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.

Item

http://www.wikidata.org/entity/Q50506281

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Gene-expression signature of t ...... l-based adjuvant chemotherapy.

@en

Gene-expression signature of t ...... l-based adjuvant chemotherapy.

@nl

type

Item

label

Gene-expression signature of t ...... l-based adjuvant chemotherapy.

@en

Gene-expression signature of t ...... l-based adjuvant chemotherapy.

@nl

prefLabel

Gene-expression signature of t ...... l-based adjuvant chemotherapy.

@en

Gene-expression signature of t ...... l-based adjuvant chemotherapy.

@nl

P1476

Gene-expression signature of t ...... l-based adjuvant chemotherapy.

@en

P2093

Aurea Mira

http://www.w3.org/2001/XMLSchema#string

Carlos Hörndler

http://www.w3.org/2001/XMLSchema#string

Christoph Petry

http://www.w3.org/2001/XMLSchema#string

Gina Ramírez

http://www.w3.org/2001/XMLSchema#string

Javier Ortego

http://www.w3.org/2001/XMLSchema#string

Joan Maurel

http://www.w3.org/2001/XMLSchema#string

Juan José Lozano

http://www.w3.org/2001/XMLSchema#string

Kerstin Bohmann

http://www.w3.org/2001/XMLSchema#string

Luis Lasalvia

http://www.w3.org/2001/XMLSchema#string

Maribel Mármol

http://www.w3.org/2001/XMLSchema#string

P2860

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

Systematic review of microsatellite instability and colorectal cancer prognosis

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

Cancer statistics, 2009

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.

Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression.

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin

P304

1090-1097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.27747

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Antoni Castells

P577

2012-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22833293

http://www.w3.org/2001/XMLSchema#string